FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula (I) or to its salt or ester in which radicals and symbols have the values presented in claim 1. These compounds are ACC inhibitors.
EFFECT: production of compounds to be applied as a therapeutic agent for various ACC-related disorders such as bacony liver, hyperlipidemia, obesity and diabetes.
13 cl, 48 ex
Title | Year | Author | Number |
---|---|---|---|
AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
SPIROPIPERIDINES, METHODS OF THEIR SYNTHESIS (VARIANTS) | 1993 |
|
RU2168512C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
SPIROCYCLIC PYRROLOPYRAZINE(PIPERIDINE)AMIDES AS IONIC CHANNELS MODULATORS | 2012 |
|
RU2634900C2 |
PYRAZOLE DERIVATIVES | 2004 |
|
RU2332412C2 |
ARYLCARBONYL DERIVATIVES AS THERAPEUTIC AGENTS | 2003 |
|
RU2340605C2 |
NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
SPIROCYCLIC AMINE DERIVATIVES AS S1P MODULATORS | 2011 |
|
RU2602800C2 |
SUBSTITUTED PYRAZOLOAZEPINE-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 2016 |
|
RU2762279C2 |
VANILLOID RECEPTOR SUBTYPE 1 (VR1) ANTAGONISTS AND APPLICATION THEREOF | 2007 |
|
RU2450006C2 |
Authors
Dates
2011-06-27—Published
2006-07-14—Filed